Avivomed Inc. raises $5M; offering $12M: Form D

Avivomed Inc., a biotechnology firm, has filed a Form D with the Securities and Exchange Commission, disclosing a recent fundraising effort. According to the filing, the company is offering a total of $12 million in securities, having already raised $5 million as of April 21, 2026. The offering is structured as part of the company's ongoing capital-raising activities, with the proceeds intended to support operational and developmental needs.

This fundraising follows several recent financing rounds, including a $2.7 million seed round on April 20, 2026, and additional seed and conventional debt rounds totaling over $70 million on April 17, 2026. Investors participating in these rounds include a mix of institutional and private entities, reflecting continued interest in Avivomed's business model and growth trajectory.

The Form D filing is a standard requirement for private placements under Regulation D of the SEC, and it provides transparency to regulatory authorities regarding the nature and scale of the offering. Investors are advised to review the full Form D and related disclosures for detailed terms and risks associated with the investment.